High Dose C6 Ceramide-Induced Response in Embryonic Hippocampal Cells.

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Ceramide plays a crucial role in central nervous system physiology and pathology.
• Its effects on embryonic/stem cells are well-documented.
• Investigating dose-dependent ceramide effects is vital for understanding neuronal differentiation and glioblastoma treatment.

Purpose of the Study:

• To investigate the impact of a high dose of ceramide (13 µM) on HN9.10e cells.
• To determine if high ceramide doses induce neuronal differentiation without disrupting sphingolipid metabolism.
• To explore the cytotoxic potential of high ceramide doses in glioblastoma.

Main Methods:

• Cell viability assays.
• Mitochondrial quantification.
• Microscopic and morphometric analysis of neuronal differentiation.
• Lipidomic analysis of ceramide and sphingolipid species.
• Gene expression analysis of key sphingolipid metabolism enzymes (SMPD3, ASAH2, SPHK2).

Main Results:

• 13 µM ceramide initially increased cell viability and mitochondrial content.
• High ceramide dose (13 µM) reduced differentiated cell numbers but increased neurite length compared to 0.1 µM.
• Lipidomic analysis revealed increased medium-long-chain ceramide, sphingomyelin, and sphingosine-1-phosphate.
• Sphingolipid alterations correlated with changes in SMPD3, ASAH2, and SPHK2 gene expression.

Conclusions:

• Ceramide's cellular response is concentration-dependent.
• Low ceramide doses promote neuronal differentiation without altering sphingolipid metabolism.
• High ceramide doses induce distinct cellular responses, impacting differentiation and sphingolipid metabolism, with potential implications for glioblastoma therapy.